Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 +0.01 (+0.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) FCF Margin (2024 - 2025)

Updated

Analysis

Telomir Pharmaceuticals (TELO) FCF Margin (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.82%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 18.33%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 26.96%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.55%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.70%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 44.00%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.01%
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -2,128.52%
Jun 30, 2025 -2,998,077.27%
Mar 31, 2025 -11,315.06%
Sep 30, 2024 -6,489.88%
Jun 30, 2024 -5,973.57%
API Access

Telomir Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=TELO&period=max&api_key=YOUR_API_KEY